Skip to main content
construction release_alert
The Scholars Team is working with OIT to resolve some issues with the Scholars search index
cancel
Journal cover image

Genetically predicted lipoprotein(a) associates with coronary artery plaque severity independent of low-density lipoprotein cholesterol.

Publication ,  Journal Article
Clarke, SL; Huang, RDL; Hilliard, AT; Levin, MG; Sharma, D; Thomson, B; Lynch, J; Tsao, PS; Gaziano, JM; Assimes, TL; VA Million Veteran Program
Published in: Eur J Prev Cardiol
January 27, 2025

AIMS: Elevated lipoprotein(a) [Lp(a)] is a causal risk factor for atherosclerotic cardiovascular disease, but the mechanisms of risk are debated. Studies have found inconsistent associations between Lp(a) and measurements of atherosclerosis. We aimed to assess the relationship between Lp(a), low-density lipoprotein cholesterol (LDL-C), and coronary artery plaque severity. METHODS AND RESULTS: The study population consisted of participants of the Million Veteran Program who have undergone an invasive angiogram. The primary exposure was genetically predicted Lp(a) estimated by a polygenic score. Genetically predicted LDL-C was also assessed for comparison. The primary outcome was coronary artery plaque severity categorized as normal, non-obstructive disease, one-vessel disease, two-vessel disease, and three-vessel or left main disease. Among 18 927 adults of genetically inferred European ancestry and 4039 adults of genetically inferred African ancestry, we observed consistent associations between genetically predicted Lp(a) and obstructive coronary plaque, with effect sizes trending upward for increasingly severe categories of disease. Associations were independent of risk factors, clinically measured LDL-C and genetically predicted LDL-C. However, we did not find strong or consistent evidence for an association between genetically predicted Lp(a) and risk for non-obstructive plaque. CONCLUSION: Genetically predicted Lp(a) is positively associated with coronary plaque severity independent of LDL-C, consistent with Lp(a) promoting atherogenesis. However, the effects of Lp(a) may be greater for progression of plaque to obstructive disease than for the initial development of non-obstructive plaque. A limitation of this study is that Lp(a) was estimated using genetic markers and could not be directly assayed nor could apo(a) isoform size.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Eur J Prev Cardiol

DOI

EISSN

2047-4881

Publication Date

January 27, 2025

Volume

32

Issue

2

Start / End Page

116 / 127

Location

England

Related Subject Headings

  • White People
  • White
  • United States
  • Severity of Illness Index
  • Risk Factors
  • Risk Assessment
  • Plaque, Atherosclerotic
  • Phenotype
  • Middle Aged
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Clarke, S. L., Huang, R. D. L., Hilliard, A. T., Levin, M. G., Sharma, D., Thomson, B., … VA Million Veteran Program. (2025). Genetically predicted lipoprotein(a) associates with coronary artery plaque severity independent of low-density lipoprotein cholesterol. Eur J Prev Cardiol, 32(2), 116–127. https://doi.org/10.1093/eurjpc/zwae271
Clarke, Shoa L., Rose D. L. Huang, Austin T. Hilliard, Michael G. Levin, Disha Sharma, Blake Thomson, Julie Lynch, et al. “Genetically predicted lipoprotein(a) associates with coronary artery plaque severity independent of low-density lipoprotein cholesterol.Eur J Prev Cardiol 32, no. 2 (January 27, 2025): 116–27. https://doi.org/10.1093/eurjpc/zwae271.
Clarke SL, Huang RDL, Hilliard AT, Levin MG, Sharma D, Thomson B, et al. Genetically predicted lipoprotein(a) associates with coronary artery plaque severity independent of low-density lipoprotein cholesterol. Eur J Prev Cardiol. 2025 Jan 27;32(2):116–27.
Clarke, Shoa L., et al. “Genetically predicted lipoprotein(a) associates with coronary artery plaque severity independent of low-density lipoprotein cholesterol.Eur J Prev Cardiol, vol. 32, no. 2, Jan. 2025, pp. 116–27. Pubmed, doi:10.1093/eurjpc/zwae271.
Clarke SL, Huang RDL, Hilliard AT, Levin MG, Sharma D, Thomson B, Lynch J, Tsao PS, Gaziano JM, Assimes TL, VA Million Veteran Program. Genetically predicted lipoprotein(a) associates with coronary artery plaque severity independent of low-density lipoprotein cholesterol. Eur J Prev Cardiol. 2025 Jan 27;32(2):116–127.
Journal cover image

Published In

Eur J Prev Cardiol

DOI

EISSN

2047-4881

Publication Date

January 27, 2025

Volume

32

Issue

2

Start / End Page

116 / 127

Location

England

Related Subject Headings

  • White People
  • White
  • United States
  • Severity of Illness Index
  • Risk Factors
  • Risk Assessment
  • Plaque, Atherosclerotic
  • Phenotype
  • Middle Aged
  • Male